Company profile: Silicon Therapeutics
1.1 - Company Overview
Company description
- Provider of fully integrated drug design, research and development using a physics-driven approach coupled to chemistry and biology R&D, with a pipeline including VTAMA (Tapinarof) for plaque psoriasis; Batoclimab for autoimmune diseases (MG, TED, CIDP, Graves' Disease); IMVT-1402 (Phase 1) subcutaneous injection; Brepocitinib for dermatomyositis and non-infectious uveitis (Phase 3 for some applications); and Namilumab for sarcoidosis (Phase 2).
Products and services
- VTAMA (Tapinarof): Topical-formulation cream that treats plaque psoriasis in adults, delivering localized dermal administration to manage psoriatic plaques across affected areas
- Brepocitinib: Small-molecule therapy addressing Dermatomyositis and Non-Infectious Uveitis, in Phase 3 for some applications, developed for treatment across these specified indications
- Batoclimab: Biologic-class treatment for autoimmune diseases including Myasthenia Gravis, Thyroid Eye Disease, CIDP, and Graves' Disease, developed to address multiple established indications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Silicon Therapeutics
Trier Health
HQ: United States
Website
- Description: Provider of a smart, trusted and secure platform for digital clinical trial execution, supporting hybrid and 100% decentralized trials, enriching patient-clinician collaboration and patient engagement through analytics and deep AI, featuring VISION Recruit for AI-driven participant matching, outreach and scheduling, and VISION Engage for patient self-screening, self-scheduling, payments and profile management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trier Health company profile →
X-Chem
HQ: United States
Website
- Description: Provider of AI-driven small molecule drug discovery solutions, including ArtemisAI to analyze DEL data and predict new binders; DEL screening services across target classes; medicinal chemistry to convert hits into leads; integrated Dynamic Drug Discovery (XD3); HITMiner to expand binder predictions; and LEADChaser to advance DEL outputs through rapid design-test loops.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X-Chem company profile →
Genuity Science
HQ: United States
Website
- Description: Provider of clinco-omics data analysis solutions and genomic sequence data for researchers, with a platform for study design, sequencing, storage, interpretation, secondary analysis, and scalable analytics. Offers disease-specific clinical omics datasets (CNS, cardiometabolic, inflammatory), powered datasets, deeply phenotyped whole genomes, longitudinal data, and population-scale expertise applying deep learning to improve patient health using the human genome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genuity Science company profile →
Simulations Plus
HQ: United States
Website
- Description: Provider of ADMET and pharmacometric modeling software, including GastroPlus for absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics across administration routes in humans and animals; ADMET Predictor for compound property prediction; PKPlus for PK/TK analysis and reporting; DDDPlus for simulating in vitro dissolution to predict in vivo performance; DILIsym for drug-induced liver injury modeling; and MonolixSuite for NLME modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Simulations Plus company profile →
Intelligent Pharma
HQ: Spain
Website
- Description: Provider of computational technologies for drug discovery and related services, offering computational chemistry services to pharmaceutical companies, biotech companies and research institutes; now part of Mind the Byte.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Intelligent Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Silicon Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Silicon Therapeutics
2.2 - Growth funds investing in similar companies to Silicon Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Silicon Therapeutics
4.2 - Public trading comparable groups for Silicon Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →